Predicting Factors of Depression, Antidepressant Use and Positive Response to Antidepressants in Perinatal and Postpartum Women
- PMID: 28761500
- PMCID: PMC5510557
- DOI: 10.2174/1745017901713010049
Predicting Factors of Depression, Antidepressant Use and Positive Response to Antidepressants in Perinatal and Postpartum Women
Abstract
Background: In the United States, there is a disparity in knowledge of nationwide depression prevalence, the antidepressant use and the antidepressant responses during perinatal/postpartum periods.
Objective: This study investigated the predicting factors of depression, antidepressant use and positive antidepressant response during the perinatal/postpartum periods.
Method: The 2007-2012 National Health and Nutrition Examination Surveys (NHANES) were combined to identify adult pregnant women, those within the 18-month postpartum period (n=492) and their depression statuses via demographics, health care accessibility, antidepressant use and illicit drug use information. The characteristics of different study groups were compared (depression versus no-depression groups, antidepressant users versus non-antidepressant users, and antidepressant responders versus antidepressant non-responders). Multivariable logistic regression analysis was used to predict factors of perinatal depression (PND)/ postpartum depression (PPD), antidepressant use and antidepressant positive response in PND/PPD.
Results: PND/PPD individuals had higher rates of mental health visits. No predicting factor for developing PND/PPD was shown. Antidepressant users were significantly older with insurance and recent health checkups/ mental visits. Being below the poverty level and having some health care accessibility are predictors for being on antidepressants. Recent non-illicit drug use is a predictor for PND/PPD symptom improvement while on antidepressants.
Conclusion: The group of those with social-economic disadvantages was more likely to be on antidepressants for PND/PPD. Illicit drug users were less likely to show improvement with antidepressants. The safety and efficacy of antidepressant use during this period is controversial. More studies need to focus on the barriers involving antidepressant treatments, the safety and outcomes of antidepressants for PND/PPD management.
Keywords: Antidepressant; Depression; Illicit drug; Perinatal women; Postpartum women.
Similar articles
-
Racial and ethnic differences in the relationship between antenatal stressful life events and postpartum depression among women in the United States: does provider communication on perinatal depression minimize the risk?Ethn Health. 2018 Jul;23(5):542-565. doi: 10.1080/13557858.2017.1280137. Epub 2017 Jan 17. Ethn Health. 2018. PMID: 28095722
-
Is perinatal depression familial?J Affect Disord. 2006 Jan;90(1):49-55. doi: 10.1016/j.jad.2005.10.006. Epub 2005 Dec 5. J Affect Disord. 2006. PMID: 16337009
-
Barriers to postpartum depression treatment among Indigenous Bedouin women in Israel: A focus group study.Health Soc Care Community. 2019 May;27(3):757-766. doi: 10.1111/hsc.12693. Epub 2018 Nov 29. Health Soc Care Community. 2019. PMID: 30488992
-
Incorporating Recognition and Management of Perinatal Depression Into Pediatric Practice.Pediatrics. 2019 Jan;143(1):e20183259. doi: 10.1542/peds.2018-3259. Pediatrics. 2019. PMID: 30559120 Review.
-
"I keep it to myself": A qualitative meta-interpretive synthesis of experiences of postpartum depression among marginalised women.Health Soc Care Community. 2019 May;27(3):e23-e36. doi: 10.1111/hsc.12645. Epub 2018 Sep 4. Health Soc Care Community. 2019. PMID: 30178901 Review.
Cited by
-
Maternal depression, a hidden predictor for severe acute malnutrition in children aged 6-59 months: a case-control study at Omdurman Paediatrics Teaching Hospital, Sudan.Sudan J Paediatr. 2020;20(2):111-121. doi: 10.24911/SJP.106-1590606922. Sudan J Paediatr. 2020. PMID: 32817731 Free PMC article.
-
Does preterm birth increase the initiation of antidepressant use during the postpartum? A population-based investigation.Front Pharmacol. 2024 Mar 27;15:1325381. doi: 10.3389/fphar.2024.1325381. eCollection 2024. Front Pharmacol. 2024. PMID: 38601467 Free PMC article.
-
Depression and Its Predictors in Adults Receiving Antiretroviral Therapy.Cureus. 2025 Apr 14;17(4):e82222. doi: 10.7759/cureus.82222. eCollection 2025 Apr. Cureus. 2025. PMID: 40370921 Free PMC article.
-
Si-Ni-San Prevents Reserpine-Induced Depression by Inhibiting Inflammation and Regulating CYP450 Enzymatic Activity.Front Pharmacol. 2020 Jan 17;10:1518. doi: 10.3389/fphar.2019.01518. eCollection 2019. Front Pharmacol. 2020. PMID: 32009949 Free PMC article.
-
Anxiety and Depression Among Women Living with HIV: Prevalence and Correlations.Clin Pract Epidemiol Ment Health. 2020 Jul 21;16:59-66. doi: 10.2174/1745017902016010059. eCollection 2020. Clin Pract Epidemiol Ment Health. 2020. PMID: 32742296 Free PMC article.
References
-
- Kessler R.C., Avenevoli S., Costello E.J., Georgiades K., Green J.G., Gruber M.J., He J.P., Koretz D., McLaughlin K.A., Petukhova M., Sampson N.A., Zaslavsky A.M., Merikangas K.R. Prevalence, persistence and sociodemographic correlates of DSM-IV disorders in the national comorbidity survey replication adolescent supplement. Arch. Gen. Psychiatry. 2012;69(4):372–380. doi: 10.1001/archgenpsychiatry.2011.160. - DOI - PMC - PubMed
-
- Meltzer-Brody S., Boschloo L., Jones I., Sullivan P.F., Penninx B.W. The EPDS-Lifetime: assessment of lifetime prevalence and risk factors for perinatal depression in a large cohort of depressed women. Arch. Women Ment. Health. 2013;16(6):465–473. doi: 10.1007/s00737-013-0372-9. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources